secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0001104659-25-062639
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar Biosciences completes 1-for-30 reverse stock split effective June 24, 2025
--------------------------------------------------------------------------------

- Reverse split ratio set at 1-for-30 for common stock, par value $0.00001.
- Amendment to Second Amended and Restated Certificate of Incorporation filed.
- Fractional shares not issued; aggregate fractions sold by transfer agent and net proceeds distributed pro rata.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465925062639/0001104659-25-062639-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465925062639/tm2519011d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-062639

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer